Price Alert

Codex DNA Inc. (DNAY)

NASDAQ: DNAY · Real-Time Price · USD

1.30

0.10 (8.33%)

At close: Jan 04, 2023, 6:00 AM

Codex DNA Statistics

Share Statistics

Codex DNA has 29.48M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	29.48M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	7.53M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 79.75K, so 0% of the outstanding shares have been sold short.

Short Interest	79.75K
Short % of Shares Out	n/a
Short % of Float	0.93%
Short Ratio (days to cover)	1.45

Valuation Ratios

The PE ratio is -0.73 and the forward PE ratio is null. Codex DNA's PEG ratio is 0.07.

PE Ratio	-0.73
Forward PE	n/a
PS Ratio	1.29
Forward PS	n/a
PB Ratio	0.76
P/FCF Ratio	-0.82
PEG Ratio	0.07

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Codex DNA.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.46.

Current Ratio	4.08
Quick Ratio	3.92
Debt / Equity	0.46
Debt / EBITDA	-0.46
Debt / FCF	-0.5
Interest Coverage	40.85

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$129.41K
Profits Per Employee	$-228.41K
Employee Count	212
Asset Turnover	0.34
Inventory Turnover	5.38

Taxes

Income Tax	-24K
Effective Tax Rate	0.05%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Codex DNA's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	1.44
200-Day Moving Average	2.61
Relative Strength Index (RSI)	51.01
Average Volume (20 Days)	79,397

Income Statement

In the last 12 months, Codex DNA had revenue of 27.43M and earned -48.42M in profits. Earnings per share was -1.64.

Revenue	27.43M
Gross Profit	15.6M
Operating Income	-49.71M
Net Income	-48.42M
EBITDA	-46.48M
EBIT	-46.44M
Earnings Per Share (EPS)	-1.64

Full Income Statement

Balance Sheet

The company has 30.42M in cash and 21.43M in debt, giving a net cash position of 8.99M.

Cash & Cash Equivalents	30.42M
Total Debt	21.43M
Net Cash	8.99M
Retained Earnings	-113.74M
Total Assets	24.74M
Working Capital	1.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.72M and capital expenditures -4.47M, giving a free cash flow of -43.18M.

Operating Cash Flow	-38.72M
Capital Expenditures	-4.47M
Free Cash Flow	-43.18M
FCF Per Share	-1.47

Full Cash Flow Statement

Margins

Gross margin is 56.84%, with operating and profit margins of -181.2% and -176.5%.

Gross Margin	56.84%
Operating Margin	-181.2%
Pretax Margin	-176.59%
Profit Margin	-176.5%
EBITDA Margin	-169.44%
EBIT Margin	-181.2%
FCF Margin	-157.4%

Dividends & Yields

DNAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for DNAY.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-13.53
Piotroski F-Score	4